Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Chemotherapy sensitizes therapy-resistant cells to mild hyperthermia by suppressing heat shock protein 27 expression in triple negative breast cancer.

Shen H, Mu C, Wu X, Zhou X, Wolfram J, Shen J, Zhang D, Mai J, Xia X, Holder AM, Ferrari M, Liu X.

Clin Cancer Res. 2018 Jun 19. pii: clincanres.3872.2017. doi: 10.1158/1078-0432.CCR-17-3872. [Epub ahead of print]

PMID:
29921732
2.

Novel phase diagram behavior and materials design in heterostructural semiconductor alloys.

Holder AM, Siol S, Ndione PF, Peng H, Deml AM, Matthews BE, Schelhas LT, Toney MF, Gordon RG, Tumas W, Perkins JD, Ginley DS, Gorman BP, Tate J, Zakutayev A, Lany S.

Sci Adv. 2017 Jun 7;3(6):e1700270. doi: 10.1126/sciadv.1700270. eCollection 2017 Jun.

3.

Dihydropteridine/Pteridine as a 2H+/2e- Redox Mediator for the Reduction of CO2 to Methanol: A Computational Study.

Lim CH, Holder AM, Hynes JT, Musgrave CB.

J Phys Chem B. 2017 Apr 27;121(16):4158-4167. doi: 10.1021/acs.jpcb.7b01224. Epub 2017 Apr 18.

PMID:
28375636
4.

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F.

PLoS One. 2016 Mar 8;11(3):e0151121. doi: 10.1371/journal.pone.0151121. eCollection 2016. No abstract available.

5.

Catalytic Reduction of CO2 by Renewable Organohydrides.

Lim CH, Holder AM, Hynes JT, Musgrave CB.

J Phys Chem Lett. 2015 Dec 17;6(24):5078-92. doi: 10.1021/acs.jpclett.5b01827. Epub 2015 Dec 10.

PMID:
26722706
6.

Mechanisms of LiCoO2 Cathode Degradation by Reaction with HF and Protection by Thin Oxide Coatings.

Tebbe JL, Holder AM, Musgrave CB.

ACS Appl Mater Interfaces. 2015 Nov 4;7(43):24265-78. doi: 10.1021/acsami.5b07887. Epub 2015 Oct 22.

PMID:
26455367
7.

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F.

PLoS One. 2015 Sep 1;10(9):e0136851. doi: 10.1371/journal.pone.0136851. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0151121.

8.

Intrinsic Material Properties Dictating Oxygen Vacancy Formation Energetics in Metal Oxides.

Deml AM, Holder AM, O'Hayre RP, Musgrave CB, Stevanović V.

J Phys Chem Lett. 2015 May 21;6(10):1948-53. doi: 10.1021/acs.jpclett.5b00710. Epub 2015 May 11.

PMID:
26263275
9.

Solvent Control of Surface Plasmon-Mediated Chemical Deposition of Au Nanoparticles from Alkylgold Phosphine Complexes.

Muhich CL, Qiu J, Holder AM, Wu YC, Weimer AW, Wei WD, McElwee-White L, Musgrave CB.

ACS Appl Mater Interfaces. 2015 Jun 24;7(24):13384-94. doi: 10.1021/acsami.5b01918. Epub 2015 Jun 15.

PMID:
26036274
10.

Epithelial to mesenchymal transition is associated with rapamycin resistance.

Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F.

Oncotarget. 2015 Aug 14;6(23):19500-13.

11.

Reduction of CO2 to methanol catalyzed by a biomimetic organo-hydride produced from pyridine.

Lim CH, Holder AM, Hynes JT, Musgrave CB.

J Am Chem Soc. 2014 Nov 12;136(45):16081-95. doi: 10.1021/ja510131a. Epub 2014 Nov 4.

PMID:
25323134
12.

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.

Hassan B, Akcakanat A, Sangai T, Evans KW, Adkins F, Eterovic AK, Zhao H, Chen K, Chen H, Do KA, Xie SM, Holder AM, Naing A, Mills GB, Meric-Bernstam F.

Oncotarget. 2014 Sep 30;5(18):8544-57.

13.

Targeting the PI3-kinase/Akt/mTOR signaling pathway.

Hassan B, Akcakanat A, Holder AM, Meric-Bernstam F.

Surg Oncol Clin N Am. 2013 Oct;22(4):641-64. doi: 10.1016/j.soc.2013.06.008. Epub 2013 Aug 6. Review.

14.

Bulk and surface tunneling hydrogen defects in alumina.

Holder AM, Osborn KD, Lobb CJ, Musgrave CB.

Phys Rev Lett. 2013 Aug 9;111(6):065901. Epub 2013 Aug 8.

PMID:
23971589
15.

Roles of the Lewis acid and base in the chemical reduction of CO2 catalyzed by frustrated Lewis pairs.

Lim CH, Holder AM, Hynes JT, Musgrave CB.

Inorg Chem. 2013 Sep 3;52(17):10062-6. doi: 10.1021/ic4013729. Epub 2013 Aug 13.

PMID:
23941178
16.

Mechanism of homogeneous reduction of CO2 by pyridine: proton relay in aqueous solvent and aromatic stabilization.

Lim CH, Holder AM, Musgrave CB.

J Am Chem Soc. 2013 Jan 9;135(1):142-54. doi: 10.1021/ja3064809. Epub 2012 Dec 21.

PMID:
23214714
17.

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.

Holder AM, Gonzalez-Angulo AM, Chen H, Akcakanat A, Do KA, Fraser Symmans W, Pusztai L, Hortobagyi GN, Mills GB, Meric-Bernstam F.

Breast Cancer Res Treat. 2013 Jan;137(1):319-27. doi: 10.1007/s10549-012-2354-4. Epub 2012 Dec 4.

18.

Mouse model reveals the role of SOX7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1.

Wat MJ, Beck TF, Hernández-García A, Yu Z, Veenma D, Garcia M, Holder AM, Wat JJ, Chen Y, Mohila CA, Lally KP, Dickinson M, Tibboel D, de Klein A, Lee B, Scott DA.

Hum Mol Genet. 2012 Sep 15;21(18):4115-25. doi: 10.1093/hmg/dds241. Epub 2012 Jun 20.

19.

Genomic alterations that contribute to the development of isolated and non-isolated congenital diaphragmatic hernia.

Wat MJ, Veenma D, Hogue J, Holder AM, Yu Z, Wat JJ, Hanchard N, Shchelochkov OA, Fernandes CJ, Johnson A, Lally KP, Slavotinek A, Danhaive O, Schaible T, Cheung SW, Rauen KA, Tonk VS, Tibboel D, de Klein A, Scott DA.

J Med Genet. 2011 May;48(5):299-307. doi: 10.1136/jmg.2011.089680.

20.

Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia.

Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, Bacino C, Scaglia F, Zori RT, Cheung SW, Scott DA, Kang SH.

Am J Med Genet A. 2009 Aug;149A(8):1661-77. doi: 10.1002/ajmg.a.32896.

21.

Racial microaggressions in everyday life: implications for clinical practice.

Sue DW, Capodilupo CM, Torino GC, Bucceri JM, Holder AM, Nadal KL, Esquilin M.

Am Psychol. 2007 May-Jun;62(4):271-86. Review.

PMID:
17516773
22.

Genetic factors in congenital diaphragmatic hernia.

Holder AM, Klaassens M, Tibboel D, de Klein A, Lee B, Scott DA.

Am J Hum Genet. 2007 May;80(5):825-45. Epub 2007 Apr 4. Review.

23.

Fine-Lubinsky syndrome: sibling pair suggests possible autosomal recessive inheritance.

Holder AM, Graham BH, Lee B, Scott DA.

Am J Med Genet A. 2007 Nov 1;143A(21):2576-80.

PMID:
17394214
24.

Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic hernia.

Scott DA, Klaassens M, Holder AM, Lally KP, Fernandes CJ, Galjaard RJ, Tibboel D, de Klein A, Lee B.

Hum Mol Genet. 2007 Feb 15;16(4):424-30. Epub 2007 Jan 8.

PMID:
17210672
25.

The synthesis and glass-forming properties of phthalocyanine-containing poly(aryl ether) dendrimers.

Brewis M, Clarkson GJ, Helliwell M, Holder AM, McKeown NB.

Chemistry. 2000 Dec 15;6(24):4630-6.

PMID:
11192097
26.

Silicon Phthalocyanines with Axial Dendritic Substituents.

Brewis M, Clarkson GJ, Goddard V, Helliwell M, Holder AM, McKeown NB.

Angew Chem Int Ed Engl. 1998 May 4;37(8):1092-1094. doi: 10.1002/(SICI)1521-3773(19980504)37:8<1092::AID-ANIE1092>3.0.CO;2-G.

PMID:
29711019

Supplemental Content

Loading ...
Support Center